Nom du produit:3-(2-Chlorophenyl)-4-((3,5-dibromo-2-hydroxybenzylidene)amino)-1H-1,2,4-triazole-5(4H)-thione

IUPAC Name:3-(2-chlorophenyl)-4-[(E)-[(3,5-dibromo-2-hydroxyphenyl)methylidene]amino]-4,5-dihydro-1H-1,2,4-triazole-5-thione

CAS:478254-46-5
Formule moléculaire:C15H9Br2ClN4OS
Pureté:95%+
Numéro de catalogue:CM1052104
Poids moléculaire:488.58

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:478254-46-5
Formule moléculaire:C15H9Br2ClN4OS
Point de fusion:-
Code SMILES:S=C1NN=C(C2=CC=CC=C2Cl)N1/N=C/C3=CC(Br)=CC(Br)=C3O
Densité:
Numéro de catalogue:CM1052104
Poids moléculaire:488.58
Point d'ébullition:
N° Mdl:MFCD03675059
Stockage:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.